Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

Return to program book search

Session Information

FOC U040 - Novel Therapies to Treat Chronic Pruritus

Open admission to eligible categories, no tuition or ticket


Date: Sunday, March 23

CME Credits: 1.00

Location: Room 704/706

Time: 7:00 AM - 8:00 AM

Director: Sarina Elmariah, MD, FAAD - Handout

Learning Objectives:
Following this course, the attendee should be able to:

  • Treat patients with neuromodulatory agents to reduce pruritus from primary cutaneous or systemic disease.
  • Discuss the mechanisms of action, side effects and efficacy of antidepressant and analgesic therapy for chronic pruritus.
  • Identify patients who may benefit from neuromodulatory therapy for chronic pruritus.

Chronic pruritus, arising idiopathically or in association with cutaneous or systemic disease, may be incapacitating. This session is meant for the clinician who wants to expand his or her armamentarium of therapeutic agents to treat this all-too-common problem. First, the neurophysiologic and neurochemical basis of chronic pruritus will be reviewed. The clinician will be introduced to neuromodulatory agents that will help manage even the most challenging cases of chronic itch. Therapeutic regimens will be outlined and the safety, efficacy, and side effects of voltage-gated calcium channel blockers, selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, analgesics and other neuromodulatory agents will be discussed.